S. Silber

发表

Coronary stenting with the Genous™ Bio-Engineered R Stent™ in elderly patients.

P. Damman, A. Íñiguez, M. Klomp, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Coronary Stenting With the Genous(TM) Bio-Engineered R Stent(TM) in Elderly Patients

P. Damman, A. Íñiguez, M. Klomp, 2011 .

Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.

P. Damman, M. Klomp, M. Beijk, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference

V. Fuster, S. Lévy, A. Parkhomenko, 2001, Circulation.

Universal definition of myocardial infarction.

Fred S Apple, Silvia G Priori, Jeroen J. Bax, 2007, Journal of the American College of Cardiology.

The predictive value of different measures of obesity for incident cardiovascular events and mortality.

Henry Völzke, Nele Friedrich, Matthias Nauck, 2010, The Journal of clinical endocrinology and metabolism.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).

G. Mancia, S. Silber, S. Ebrahim, 2004, Archives des maladies du coeur et des vaisseaux.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit

Shah Ebrahim, Harry Hemingway, Silvia G Priori, 2007, European heart journal.

Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

Michael Böhm, Anna Strömberg, Piotr Ponikowski, 2008, European journal of heart failure.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Piotr Ponikowski, Jose Luis Zamorano, Giuseppe Mancia, 2007, European heart journal.

2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

Helmut Baumgartner, Volkmar Falk, Marco Valgimigli, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[Guidelines for cardiac pacing and cardiac resynchronization therapy].

Richard Sutton, Hugo Ector, Silvia G Priori, 2008, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I

Volkmar Falk, Patrick W Serruys, Philippe Kolh, 2022 .

The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data

R. Holle, J. Brachmann, S. Silber, 2014, PloS one.

ESC / EACTS Guidelines on myocardial revascularization

Helmut Baumgartner, Joel Dunning, Holger Thiele, 2014 .

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Shah Ebrahim, Ian Graham, Giuseppe Mancia, 2003 .

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Shah Ebrahim, Ian Graham, Giuseppe Mancia, 2004, European heart journal.

JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda

Shah Ebrahim, Ian Graham, Giuseppe Mancia, 2016 .

Impact of left ventricular function on clinical outcomes among patients with coronary artery disease

P. Serruys, L. Räber, S. Silber, 2019, European journal of preventive cardiology.

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.

P. Serruys, L. Räber, S. Silber, 2016, American heart journal.

Risk of Myocardial Infarction Following Coronary Stent Implantation without Adequate Clopidogrel Treatment

S. Silber, M. Borggrefe, M. Böhm, 2006 .

Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis: Results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST)

S. Silber, D. Ramsdale, C. Hamm, 2002, Circulation.

Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program.

P. Serruys, S. Silber, S. Windecker, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program.

A. Yeung, P. Serruys, S. Silber, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Thrombozytenhemmung doppelt und für drei zusätzliche Jahre?

S. Silber, 2017, MMW - Fortschritte der Medizin.

Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.

S. Silber, A. Kirtane, S. Windecker, 2014, European heart journal.

Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.

P. Serruys, S. Silber, F. Neumann, 2013, JACC. Cardiovascular interventions.

Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines

P. Kolh, F. Van de Werf, S. Silber, 2012, Expert review of cardiovascular therapy.

ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

M. Pfisterer, E. Braunwald, P. Serruys, 2008, European heart journal.

Guidelines on myocardial revascularization.

Volkmar Falk, Patrick W Serruys, Philippe Kolh, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions.

F. Eberli, P. Serruys, S. Silber, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.

A. Yeung, V. Novack, P. Serruys, 2013, JACC. Cardiovascular interventions.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

S. Silber, H. Ince, T. Helms, 2011, Deutsche medizinische Wochenschrift.

Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.

P. Serruys, L. Räber, S. Silber, 2015, JACC. Cardiovascular interventions.

The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.

S. Silber, P. Stella, G. Sangiorgi, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting

P. Serruys, G. Stone, S. Silber, 2012, Heart.

ISCHEMIA trial: The long-awaited evidence to confirm our prejudices.

S. Silber, B. Ibáñez, M. Jaguszewski, 2020, Cardiology journal.

Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease

P. Serruys, L. Räber, S. Silber, 2022 .

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention

P. Serruys, S. Silber, S. Windecker, 2014, Journal of the American College of Cardiology.

Interventional Cardiology 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents A Report From the RESOLUTE All-Comers Trial ( A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutan

P. Serruys, S. Silber, S. Windecker, 2022 .

Positionspapier zur Statintherapie

E. Fleck, J. Brachmann, S. Silber, 2007 .

Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology

A. Parkhomenko, S. Silber, W. Klein, 2003 .

[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].

Michael Weis, Volkmar Falk, Franz Weidinger, 2009, Giornale italiano di cardiologia.

Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology.

G. Filippatos, S. Silber, N. Danchin, 2005, European heart journal.

Mesh-Covered Embolic Protection Stent Implantation in ST-Segment–Elevation Myocardial Infarction: Final 1-Year Clinical and Angiographic Results From the MGUARD for Acute ST Elevation Reperfusion Trial

G. Stone, S. Silber, D. Dudek, 2015, Circulation. Cardiovascular interventions.

[ESH/ESC 2007 Guidelines for the management of arterial hypertension].

Piotr Ponikowski, Giuseppe Mancia, Margus Viigimaa, 2007, Revista espanola de cardiologia.

[Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry].

S. Silber, R. Schmieder, B. Richartz, 2007, Deutsche medizinische Wochenschrift.

Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial).

G. Stone, S. Silber, D. Dudek, 2015, The American journal of cardiology.

A new and rapid scoring system to assess the scientific evidence from clinical trials.

S. Silber, 2006, Journal of interventional cardiology.

Measuring Abdominal Obesity: Effects of Height on Distribution of Cardiometabolic Risk Factors Risk Using Waist Circumference and Waist-to-Height Ratio

S. Silber, H. Wittchen, G. Stalla, 2011, Diabetes Care.

The Diagnosis of Chronic Coronary Heart Disease.

E. Fleck, S. Silber, J. Barkhausen, 2017, Deutsches Arzteblatt international.

Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis Results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST)

S. Silber, D. Ramsdale, C. Hamm, 2002 .

Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials

P. Serruys, S. Silber, F. Mohr, 2014, Heart.

Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).

S. Silber, C. Di Mario, M. Morice, 2004, Journal of the American College of Cardiology.

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.

P. Teirstein, W. Laskey, S. Silber, 2003, International journal of radiation oncology, biology, physics.

[The value of the thallium-201 scintigram as compared with the exercise electrocardiogram in patients with coronary artery disease but no myocardial infarction (author's transl)].

E. Fleck, S. Silber, W. Rudolph, 1979, Herz.

Percutaneous Coronary Intervention in Stable Coronary Heart Disease -Is Less More?

S. Silber, H. Thiele, L. Maier, 2020, Deutsches Arzteblatt international.

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention.

P. Serruys, S. Silber, P. Jüni, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents.

P. Serruys, S. Silber, S. Garg, 2011, American heart journal.

Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial

G. Stone, S. Silber, M. Leon, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).

G. Mancia, S. Silber, G. De Backer, 2004, Atherosclerosis.

Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial).

G. Stone, S. Silber, D. Dudek, 2014, The American journal of cardiology.

ESC-Leitlinie 2019 zum chronischen Koronarsyndrom (CCS, vormals „stabile KHK“)

S. Silber, 2019, Herz.

Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.

S. Silber, W. März, H. Wittchen, 2008, European journal of endocrinology.

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies.

P. Serruys, S. Silber, S. Windecker, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC].

G. Stone, S. Silber, A. Colombo, 2005, Kardiologia polska.

Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation.

P. Serruys, S. Silber, S. Windecker, 2013, Contemporary Clinical Trials.

High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.

S. Silber, C. Di Mario, A. Lansky, 2004, Journal of the American College of Cardiology.

[Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)].

S. Silber, H. Wittchen, A. Zeiher, 2008, Medizinische Klinik.

Abstract 16180: Prognostic Implications Of Circulating miRs As Biomarkers In Cardiovascular Primary Prevention - Results From The Population-based DETECT-study

S. Silber, H. Wittchen, H. Lehnert, 2012 .

Final report of the European multi-center registry using the Deutt™ vascular sealing device

S. Silber, E. Grube, A. Tofte, 1999, Herz.

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

P. Serruys, S. Silber, S. Windecker, 2019, JACC. Cardiovascular interventions.

Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina.

F. Eberli, P. Serruys, S. Silber, 2011, International journal of cardiology.

Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry.

S. Silber, K. Kuck, C. Nienaber, 2012, Journal of interventional cardiology.

Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.

P. Serruys, S. Silber, F. Neumann, 2013, International journal of cardiology.

Longitudinal change instead of baseline testosterone predicts depressive symptoms

S. Silber, W. März, H. Wittchen, 2018, Psychoneuroendocrinology.

Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions.

P. Serruys, S. Silber, F. Neumann, 2014, The Journal of invasive cardiology.

Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, W. O’Neill, 2005 .

Two-year clinical follow-up of Sr/Y h-radiation versus placebo control for the treatment of in-stent restenosis

Samin K. Sharma, P. Teirstein, S. Silber, 2005 .

Successful reduction of in-stent restenosis in long lesions using beta-radiation--subanalysis from the RENO registry.

P. Serruys, S. Silber, A. Colombo, 2004, International journal of radiation oncology, biology, physics.

Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registry.

S. Silber, P. Coucke, K. Wegscheider, 2003, The Journal of invasive cardiology.

Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007

M. Pfisterer, P. Serruys, S. Silber, 2009 .

Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: Insights from the NIRTOP study

B. Lewis, S. Silber, R. Kornowski, 2008, Acute cardiac care.

Five year clinical outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System

V. Novack, S. Silber, P. Meraj, 2022, Cardiovascular Revascularization Medicine.

TCT-41 One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Primary PCI

G. Stone, S. Silber, D. Dudek, 2013 .

Performance of the resolute zotarolimus‐eluting stent in small vessels

A. Yeung, P. Serruys, S. Silber, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial.

P. Serruys, S. Silber, W. Wijns, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].

S. Silber, F. Fricke, 2005, Herz.

THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT

A. Yeung, P. Serruys, S. Silber, 2013 .

Safety of Asynchronous Ventricular Pacemaker Stimulation

E. Fleck, J. Brachmann, W. Hemmer, 2005 .

[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].

S. Silber, B. Richartz, Matthias Brilmayer, 2006, Herz.

[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].

S. Silber, M. Borggrefe, M. Böhm, 2008, Clinical research in cardiology : official journal of the German Cardiac Society.

Capturing circulating endothelial progenitor cells: a new concept tested in the HEALING studies.

S. Silber, 2006, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.

Effects of a new vascular sealing device on coagulation parameters and thrombin generation in humans

S. Silber, M. Spannagl, W. Schramm, 1998 .

Clinical and angiographic acute and follow up results of intracoronary β brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary β brachytherapy (RENO)

S. Silber, E. Regar, A. Colombo, 2003, Heart.

[Optimal platelet inhibition after coronary stent implantation. Current status].

S. Silber, C. Bode, H. Hoffmeister, 2008, Herz.

Cardiovascular risk algorithms in primary care: Results from the DETECT study

S. Silber, W. März, U. Laufs, 2019, Scientific Reports.

Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents

S. Silber, K. Kuck, C. Nienaber, 2013, Clinical Research in Cardiology.

Prognostic value of reported chest pain for cardiovascular risk stratification in primary care

S. Silber, W. März, H. Wittchen, 2014, European journal of preventive cardiology.

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Antonio Colombo, Erik Jørgensen, Per Albertsson, 2005, European heart journal.

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

M. Pfisterer, E. Braunwald, P. Serruys, 2009, EuroIntervention.

TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions

Mary E. Russell, S. Silber, K. Hauptmann, 2003, Circulation.

Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial

P. Serruys, S. Silber, S. Windecker, 2011, European heart journal.

Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.

P. Serruys, L. Räber, S. Silber, 2012, JACC. Cardiovascular interventions.

[Guidelines for percutaneous coronary interventions].

Antonio Colombo, Erik Jørgensen, Per Albertsson, 2005, Revista espanola de cardiologia.

THE BOSTON SCIENTIFIC ANTIPROLIFERATIVE , PACLITAXEL ELUTING STENTS ( TAXUS )

S. Silber, E. Grube, 2001 .

Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

S. Silber, D. Dudek, A. Colombo, 2003, Circulation.

Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients

P. Serruys, L. Räber, S. Silber, 2016, Circulation. Cardiovascular interventions.

[European study of ambulatory management of heart failure by cardiologists].

S. Silber, M. Komajda, F. Sonntag, 2004, Revista espanola de cardiologia.

Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention

S. Silber, J. Kotzerke, 2012 .

Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial.

G. Stone, S. Silber, D. Dudek, 2012, Journal of the American College of Cardiology.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

Sr/Y -Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90 Sr / 90 Y-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

Richard R. Heuser, Theodore A. Bass, Jeffrey J. Popma, 2002 .

Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics

F. Eberli, P. Serruys, S. Silber, 2010, Clinical Research in Cardiology.

Treatment of in-stent restenosis by combining cutting balloon angioplasty and vascular brachytherapy: a report from the RENO registry

S. Silber, P. Coucke, P. Urban, 2002 .

A multicentre European registry of intraluminal coronary beta brachytherapy.

P. Serruys, S. Silber, P. Serruys, 2003, European heart journal.

EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention.

P. Serruys, S. Silber, E. Boersma, 2011, European heart journal.

Intracoronary brachytherapy, a promising treatment option for diabetic patients: Results from a European multicenter registry (RENO)

P. Serruys, S. Silber, H. Eggebrecht, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study.

S. Silber, W. J. van der Giessen, P. Serruys, 2002, European heart journal.

Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry.

P. Damman, M. Klomp, M. Beijk, 2011, Journal of interventional cardiology.

CORONARY ARTERY DISEASE Twelve-month Outcomes After Coronary Stenting

M. Klomp, M. Beijk, S. Silber, 2011 .

Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

P. Damman, M. Klomp, M. Beijk, 2012, Heart and Vessels.

A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.

S. Silber, W. Daniel, H. Drexler, 2006, American heart journal.

The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents

P. Serruys, L. Räber, S. Silber, 2014, PloS one.

[Impact of both cardiac-CT and cardiac-MR on the assessment of coronary risk].

S. Silber, B. Richartz, Stellenwert von Kardio-CT, 2005, Zeitschrift fur Kardiologie.

Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program

S. Silber, W. März, H. Wittchen, 2005, Current medical research and opinion.

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial

P. Serruys, S. Silber, S. Windecker, 2011, The Lancet.

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial.

P. Serruys, S. Silber, H. Suryapranata, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction

S. Silber, C. Bode, J. Schofer, 2004, Herz.

Herz Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction Present Data from Nonrandomized Studies

S. Silber, C. Bode, J. Schofer, 2004 .

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study

S. Silber, W. März, H. Wittchen, 2013, Clinical Research in Cardiology.

Resting heart rate as a tool for risk stratification in primary care

S. Silber, W. März, H. Wittchen, 2012, European journal of preventive cardiology.

Resting heart rate as a tool for risk stratification in primary care : does it provide incremental prognostic

Winfried März, Hendrik Lehnert, Hans-Ulrich Wittchen, 2012 .

Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study

S. Silber, M. Kleber, H. Scharnagl, 2020, Scientific Reports.

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Volker Klauss, Patrick W Serruys, William Wijns, 2010, The New England journal of medicine.

Improved risk stratification in prevention by use of a panel of selected circulating microRNAs

S. Silber, U. Völker, S. Baumeister, 2017, Scientific Reports.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.

S. Silber, W. März, H. Wittchen, 2012, Clinical chemistry.

Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions

S. Silber, D. Baim, D. Dudek, 2009, Circulation.

Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain

S. Blankenberg, S. Silber, B. Lindahl, 2018, Scientific Reports.

'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study.

B. Lewis, S. Silber, R. Kornowski, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The NUGGET study: NIR ultra gold‐gilded equivalency trial

S. Silber, J. Webb, M. Morice, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

UvA-DARE ( Digital Academic Repository ) Coronary Stenting With the Genous ( TM ) Bio-Engineered R Stent ( TM ) in Elderly Patients Damman

P. Damman, A. Íñiguez, M. Klomp, 2011 .

The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.

R. Whitbourn, S. Silber, K. Sim, 2013, JACC. Cardiovascular interventions.

Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients

Martin Wehling, Winfried März, Hendrik Lehnert, 2012, PloS one.

[Cardiovascular high-risk constellations in primary care. DETECT Study 2003].

S. Silber, W. März, H. Wittchen, 2005, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial—Phase 2

P. Serruys, S. Silber, H. Suryapranata, 2009, Circulation. Cardiovascular interventions.

Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany.

S. Silber, H. Scharnagl, H. Wittchen, 2007, Atherosclerosis.

CORONARY ARTERY DISEASE Original Studies Impact of Diabetes Mellitus Status on Coronary Pathoanatomy and Interventional Treatment: Insights From the Euro Heart Survey PCI registry

F. Eberli, P. Serruys, S. Silber, 2011 .

Kennen Sie Ihr Herzinfarktrisiko?

S. Silber, 2018, MMW - Fortschritte der Medizin.

Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).

S. Willich, S. Silber, K. Kuck, 2009, The American journal of cardiology.

5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program.

S. Silber, S. Saito, F. Neumann, 2017, JACC. Cardiovascular interventions.

Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).

S. Silber, K. Hauptmann, M. Russell, 2005, The American journal of cardiology.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Cloud Super-cooled Liquid Water Estimation From Satellite Data

S. Silber, W. Porch, J. Roskovensky, 2010 .

Transferability of data between different drug-eluting stents.

P. Serruys, S. Silber, Y. Onuma, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Cypher versus taxus: are there differences?

S. Silber, 2005, Journal of interventional cardiology.

The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent

S. Silber, S. Saito, M. Leon, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program

A. Yeung, P. Serruys, S. Silber, 2013, Heart.

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study

J. Hoyer, S. Silber, W. März, 2018, PloS one.

Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings.

S. Silber, R. Hoffmann, P. Hanrath, 2002, The American journal of cardiology.

Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data

R. Holle, J. Brachmann, S. Silber, 2014, BMC Health Services Research.

Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.

S. Silber, P. Stella, G. Sangiorgi, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients.

P. Serruys, S. Silber, R. D. de Winter, 2011, Atherosclerosis.

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent).

P. Serruys, S. Silber, R. D. de Winter, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry

P. Damman, M. Klomp, M. Beijk, 2012, Coronary artery disease.

Direct Stenting with TAXUS Stents Seems to be as Safe and Effective as with Predilatation

Antonio Colombo, Jorge Belardi, M. Pfisterer, 2004, Herz.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.

P. Serruys, S. Silber, J. Wykrzykowska, 2011, JACC. Cardiovascular interventions.

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents

P. Serruys, S. Silber, J. Iqbal, 2015, Circulation. Cardiovascular interventions.

Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous™ bio‐engineered R stent™ in patients from the e‐healing registry

P. Damman, M. Klomp, M. Beijk, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.

P. Serruys, S. Silber, H. Suryapranata, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

DRUG ELUTING STENTS Cypher Versus Taxus : Are There Differences ?

S. Silber, 2005 .

The Boston Scientific Antiproliferative, Paclitaxel Eluting Stents (TAXUS)

S. Silber, E. Grube, 2001 .

9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.

V. Novack, S. Silber, P. Meraj, 2017, JACC. Cardiovascular interventions.

The REMEDEE trial: 5‐Year results on a novel combined sirolimus‐eluting and endothelial progenitor cells capturing stent

S. Silber, K. Sim, R. Mehran, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002].

S. Silber, M. Kaltenbach, W. Haerer, 2003, Herz.

Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent.

P. Serruys, S. Silber, R. D. de Winter, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical and angiographic acute and follow up results of intracoronary b brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary b brachytherapy (RENO)

S. Silber, A. Colombo, E. Regar, 2003 .

[Waiting times and death on the waiting list for coronary artery bypass operation. Experiences in Munich with over 1,000 patients].

S. Silber, R. Dörr, G. Zindler, 1996, Herz.

[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].

S. Silber, 2010, Herz.

Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002, Circulation.

A case report of the new Polyzene™-F COBRA PzF™ Nanocoated Coronary Stent System (NCS): Addressing an unmet clinical need.

S. Silber, Panorea Styllou, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Cardiovascular Revascularization Medicine A case report of the new Polyzene TMF COBRA PzF TM Nanocoated Coronary Stent System ( NCS ) : Addressing an unmet clinical need ☆

S. Silber, Panorea Styllou, 2016 .

Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

P. Serruys, L. Räber, S. Silber, 2016, The American journal of cardiology.

The universal definition of myocardial infarction

Jeroen J. Bax, N. Al-Attar, R. de Caterina, 2015, Oxford Medicine Online.

Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany: Results of the 9th Survey

S. Silber, C. Rischpler, O. Lindner, 2023, Nuklearmedizin - NuclearMedicine.

Myocardial perfusion SPECT in Germany from 2012 to 2021: insights into development and quality indicators

S. Silber, W. Burchert, C. Rischpler, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

[Practice guidelines 2007 for the treatment of arterial hypertension].

R. de Caterina, A. Dominiczak, J. Camm, 2007, Giornale italiano di cardiologia.

Thrombozytenhemmung doppelt und für drei zusätzliche Jahre?

S. Silber, S. Silber, 2017, MMW - Fortschritte der Medizin.

Abstract 5998: Final Results of the HEALING 2B Trial to Evaluate a Bioengineered CD34 Antibody Coated Stent (GenousTMStent) Designed to Promote Vascular Healing by Capture of Circulating Endothelial Progenitor Cells in CAD Patients

P. Serruys, S. Silber, M. Grisold, 2008 .

Drug-eluting Stents: Durchbruch oder Zeitbombe?

S. Silber, T. Lüscher, 2007, Herz Kardiovaskuläre Erkrankungen.

Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry

S. Willich, S. Silber, K. Kuck, 2011, Clinical Research in Cardiology.

SCOREO trial interim safety results: despite efficacy, late stent thrombosis with the QuaDDS-QP2 stent

S. Silber, J. Fajadet, A. Colombo, 2002 .

Angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis Clinical and angiographic results from a randomized multicenter trial

S. Silber, F. Schiele, Eulogio J. García, 2000 .

THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

A. Yeung, P. Serruys, S. Silber, 2012 .

Universal definition of myocardial infarction.

Jeroen J. Bax, Joseph S Alpert, Kristian Thygesen, 2007 .

European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

G. Mancia, S. Silber, S. Ebrahim, 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

G. Mancia, S. Silber, G. De Backer, 2003, European heart journal.

Impact of body mass index on long‐term clinical outcomes after second‐generation drug eluting stent implantation: Insights from the international global RESOLUTE program

A. Yeung, P. Serruys, S. Silber, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Guidelines on myocardial revascularization.

P. Kolh, P. Serruys, S. Silber, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial

P. Serruys, S. Silber, J. Wykrzykowska, 2013, Heart.

P. Damman, M. Klomp, M. Beijk, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abstract 6000: Clinical Outcome for the Endothelial Progenitor Cells Capturing Genous Stent: First Results of the 1-Year Follow-Up in 5000 Patients

S. Silber, E. Ribeiro, H. Suryapranata, 2008 .

SCORE six-month angiographic results: improved restenosis in patients receiving the QUADDS-QP2 drug-eluting stent compared with the control, bare stents

S. Silber, A. Lansky, J. Fajadet, 2002 .

Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology

A. Parkhomenko, S. Silber, W. Klein, 2003 .

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.

S. Silber, F. Neumann, A. Zaman, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.

S. Silber, W. März, H. Wittchen, 2012, Clinical chemistry.

[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].

G. Lip, N. Al-Attar, R. de Caterina, 2009, Giornale italiano di cardiologia.

Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial).

G. Stone, S. Silber, D. Dudek, 2015, The American journal of cardiology.

Kardiovaskuläre Risikoabschätzung in der Hausarztpraxis (DETECT)

S. Silber, S. Silber, H. Wittchen, 2008, Medizinische Klinik.